3
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Central serous chorioretinopathy and bullous retinal detachment: a rare association

, BAppSc (Optom) (Hons) PhD (Dr) & , MB BS FRANZCO FRACS
Pages 248-252 | Received 26 Feb 2010, Accepted 20 Jun 2005, Published online: 15 Apr 2021

REFERENCES

  • Spitznas M., Huke J.. Number, shape and topography of leakage points in acute type I central serous retinopathy. Graefe's Arch Clin Exp Ophthalmol 1987; 225: 437–440.
  • Vukojević N., Sikić J., Katusić D., Sarić B.. Types of central serous retinopathy, analysis of shape, topographic distribution and number of leakage sites. Coll Antropol 2001; 25: 83–87.
  • Yannuzzi LA. Type‐A behavior and central serous chorioretinopathy. Retina 1987; 7: 111–130.
  • Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central choroidopathy. Am J Ophthalmol 1967; 63: 587–615.
  • Bouzas EA, Karadimas P., Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431–448.
  • Gass JDM. Stereoscopic Atlas of Macular Diseases, 4th ed. Missouri: Mosby‐Year Book Inc; 1997. p 52–69.
  • Gass JDM. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: OP456–467.
  • Flicker L., Vafidis G., While A., Leaver P.. Long‐term follow‐up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988; 72: 829–834.
  • Leaver P., Williams C.. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979; 63: 674–677.
  • Wakakura M., Ishikawa S.. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984; 68: 329–331.
  • Carvalho‐recchia CA, Yannuzzi LA, Negrão S., Spaide RF, Freund KB, Rodriguez‐coleman H., Lenharo M., Iida T.. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002; 109: 1834–1837.
  • Koyama M., Mizota A., Igarashi Y., Adachi‐usami E.. Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy. Ophthalmologica 2004; 218: 107–110.
  • Gass JDM. Bullous retinal detachment: an unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 1973; 75: 810–821.
  • Kayazawa F.. Central serous choroidopathy with exudative retinal detachment. Ann Ophthalmol 1982; 14: 1035–1042.
  • Benson WE, Shields JA, Annesley WHJ, Tasman W.. Idiopathic central serous chorioretinopathy with bullous retinal detachment. Ann Ophthalmol 1980; 12: 920–924.
  • Sahu DK, Namperumalsamy P., Hilton GF, de Sousa NF. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2000; 84: 485–492.
  • Weiler W.. Exudative retinal detachment, pigment epithelium tear and subretinal exudate in a case of central serous retinopathy. Klin Monatsbl Augenheilkd 1991; 199: 450–453.
  • Mazzuca DE, Benson WE. Central serous retinopathy: variants. Surv Ophthalmol 1986; 31: 170–174.
  • Yang CM. Bullous retinal detachment in a patient with central serous chorioretinopathy. J Formos Med Assoc 1998; 97: 711–714.
  • Matsuo T., Nakayama T., Koyama T., Matsuo N.. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica 1987; 195: 97–102.
  • Dasatnik HR, Gutman FA. Bilateral exudative retinal detachment complicating systemic corticosteroid therapy in the presence of renal failure. Am J Ophthalmol 1996; 122: 432–434.
  • Kishi S., Yoshida O., Matsuoka R., Kojima Y.. Serous retinal detachment in patients under systemic corticosteroid treatment. Jpn J Ophthalmol 2001; 45: 640–647.
  • Gass JDM, Little H.. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995; 102: 737–747.
  • Sharma T., Shah N., Rao M., Gopal L., Shanmugam MP, Gopalakrishnan M., Bhende P., Bhende M., Shetty NS, Baluswamy S.. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 2004; 11: 1708–1714.
  • Friberg TR, Eller AW. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefe's Arch Clin Exp Ophthalmol 1990; 228: 305–309.
  • Gass JDM. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992; 110: 1717–1722.
  • Gass JDM. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991; 109: 677–681.
  • Gass JDM. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefe's Arch Clin Exp Ophthalmol 1992; 230: 454–458.
  • Verma L., Sinha R., Venkatesh P., Tewari HK. Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]. BMC Ophthalmol 2004; 4: 15.
  • Robertson D., Ilstrup D.. Direct, indirect and sham laser photocoagulation in the management of central serous retinopathy. Am J Ophthalmol 1983; 95: 457–466.
  • Yannuzzi LA, Slakter JS, Kaufman SR, Gupta KK. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 1992; 2: 103–114.
  • Burumcek E., Mudun A., Karacorlu S., Arslan MO. Laser photocoagulation for persistent central serous retinopathy: results of long‐term follow‐up. Ophthalmology 1997; 104: 616–622.
  • Wong R., Chopdar A., Brown M.. Five to 15 year follow‐up of resolved idiopathic central serous chorioretinopathy. Eye 2004; 18: 262–268.
  • Canakis C., Livir‐rallatos C., Panayiotis Z., Livir‐rallatos G., Persidis E., Conway MD, Peyman GA. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 2003; 13: 750–752.
  • Piccolino Cardillo F., Eandi CM, Ventre L., de la Longrais Rigault RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23: 752–763.
  • Otsuka S., Ohba N., Nakao K.. A long‐term follow‐up study of severe variant of central serous chorioretinopathy. Retina 2002; 22: 25–32.
  • Sharma T., Badrinath SS, Gopal L., Ravishankar K., Shanmugam MP, Bhende P., Bhende M., Shetty NS, Deshpande DA, Mukesh BN. Subretinal fibrosis and nonrhegmatogenous retinal detachment associated with multifocal central serous chorioretinopathy. Retina 1998; 18: 23–29.
  • Parodi Battaglia M., Da Pozzo S., Ravalico G.. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003; 23: 235–237.
  • Treatment of Age‐Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age‐related macular degeneration: three‐year results of an open‐label extension of 2 randomized clinical trials—TAP Report no. 5. Arch Ophthalmol 2002; 120: 1307–1314.
  • Ergun E., Tittl M., Stur M.. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 2004; 122: 37–41.
  • Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 2003; 136: 836–845.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.